Olive recently closed a $400 million funding round, raising the healthcare AI company's total valuation to $4 billion, according to a July 1 news release.
Olive's AI technologies and software are in place at more than 900 hospitals across 40 U.S. states; with the new funding, the company plans to further scale product development and expand its workforce this year, according to the report.
Olive acquired Empiric Health, an AI clinical analytics spinoff from Salt Lake City-based Intermountain Healthcare, in April.
Since forming in 2012, Olive has raised $902 million. It was last valued at $1.5 billion in December 2020.